ACTION:
Notice of registration.
SUMMARY:
The registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as a bulk manufacturer of a basic class of schedule I and II controlled substances. Information on previously published notices is listed below. No comments or objections were submitted for the notice.
Company | FR Docket | Published |
---|---|---|
Siegfried USA, LLC | March 1, 2019. | |
Patheon Pharmaceuticals, Inc | March 6, 2019. | |
S & B Pharma Inc | March 6, 2019. | |
Siemens Healthcare Diagnostics, Inc | March 21, 2019. | |
Synthcon, LLC | April 8, 2019. |
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each of the company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.
Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.
[FR Doc. 2019-21313 Filed 9-30-19; 8:45 am]
BILLING CODE 4410-09-P